i_cookie@2x

By continuing to use the site, you agree to the use of cookies. Accept Cookies or Find out more

Roy Davies – Independent Chairman : Independent Chairman

Roy Davies – Independent Chairman

Independent Chairman

MORE INFORMATION

Roy is the Company’s chairman. Roy served as the chief executive officer of Optos plc, a leading opthalmology medical device business, from 2008 until June 2016 when he stepped down following that company’s acquisition by Nikon. Before joining Optos, he served from 2007 as chief executive officer of Gyrus Group plc, a leading medical device company, prior to its acquisition by the Olympus Corporation of Japan in 2008, having previously served as Chief Operating Officer of Gyrus from 2003.

Prior to this, Mr Davis was CEO of NTERA, a nanotechnology company, and spent almost ten years with Arthur D Little, the global management consulting company, where he was Vice President and Global Head of its operations management business. Roy has also held senior positions with Tricom, Reuters and Molex. Mr Davis holds a mechanical engineering degree from the University of Southampton and an MBA from the London Business School.

Stuart Quin – Chief Executive Officer : Chief Executive Officer

Stuart Quin – Chief Executive Officer

Chief Executive Officer

MORE INFORMATION

Stuart Quin joined Medica Group in September 2019 from Synlab, the international laboratory diagnostic services provider, where he was regional Chief Executive of Central and Eastern Europe, Middle East and Africa. Previously he was Synlab’s Group Chief Commercial Officer and Chief Executive of its operations in UK and Ireland. Stuart brings a track record of delivering significant growth both in the UK and internationally and has extensive experience of working in partnership with the NHS. During Stuart’s tenure in the UK he expanded the business by winning new diagnostic service contracts and through the acquisition of four companies that significantly diversified Synlab’s service offering into drug and alcohol, specialist food and veterinary testing.

Prior to joining Synlab, Stuart worked in private equity as a Director at August Equity and for seven years at 3i in the UK and Germany where he focused on investing in healthcare. Stuart also spent four years at Accenture in the US and UK as a Manager in the health and life sciences strategy consulting practice. Stuart holds a BSc (Hons) in Immunology from the University of Edinburgh, a PhD in Immunology from Imperial College London and an MBA from INSEAD.

Steve Whittern – Senior Independent Non-Executive Director : Senior Independent Non-Executive Director

Steve Whittern – Senior Independent Non-Executive Director

Senior Independent Non-Executive Director

MORE INFORMATION

Steve currently serves as Finance Director of Dignity plc, the FTSE 250 provider of funeral-related services. He joined Dignity in 1999 from KPMG and was appointed Finance Director at the beginning of 2009, having spent the previous two years as Financial Controller, being responsible for the Group’s finance function. During his time with Dignity, Steve has led various leveraged refinancings and returns of capital as well as managing the debt and equity funding for a £58 million acquisition in 2013. Steve is an FCA and holds a mathematics degree from Warwick University.

Jo Easton – Independent Non-Executive Director : Independent Non-Executive Director

Jo Easton – Independent Non-Executive Director

Independent Non-Executive Director

MORE INFORMATION

Jo served as Group Director of HR for De La Rue plc for six years until she stepped down in March 2020. De La Rue provides products and services in the supply of Cash and Product Authentication & Traceability and works with governments and commercial organisations across the world. During this time, Jo was a member of the Executive Leadership Team focused on driving growth and reshaping the business involving a significant level of change and including a number of disposals and an acquisition. She was also the executive arm of the Remuneration Committee. Prior to joining De La Rue, Jo spent six years at Associated British Foods plc working in the Twinings business in an international HR role with responsibilities across the UK, Asia and Europe. Her previous experience includes HR roles involving major change and business transformation with Aviva plc and Zurich Insurance and in telecommunications at BT plc where Jo started her career.

Dr Stephen Griffith Davies MA, FRCP, FRCR – Medical Director and Responsible Officer : Medical Director and Responsible Officer

Dr Stephen Griffith Davies MA, FRCP, FRCR – Medical Director and Responsible Officer

Medical Director and Responsible Officer

MORE INFORMATION

Stephen joined Medica in May 2013 as Medical Director. He has responsibility for Clinical Governance and oversight of the Clinical Strategy and is the Group’s Responsible Officer under the GMC Designated Body Scheme. Stephen was an NHS Consultant Radiologist at Cwm Taf University Health Board from 1991 until 2016.

Stephen undertook pre-clinical studies at Cambridge and his clinical studies at The Royal London Hospital. He is a past President of both the British Institute of Radiology and the UK Radiology Congress. In October 2015, Stephen was awarded the Distinguished Service Medal by The British Institute of Radiology. Stephen has had Educational Leadership positions as Associate Dean in the University of Wales and with the Royal College of Radiologists.

Tony Lee – Company Secretary : Company Secretary

Tony Lee – Company Secretary

Company Secretary

MORE INFORMATION

Tony is a Chartered Accountant with over a decade of experience in the independent medical sector. Having joined Medica in 2009 he played a key role in supporting the transition of ownership from Nuffield Health to private equity ownership. Appointed as Finance Director and Company Secretary as part of the 2013 MBO Tony strengthened the finance and back end administration functions to support sustained and rapid year on year growth. After a period of successful private ownership, Tony played a pivotal role in transitioning the business from private equity ownership to listed status in March 2017. Since 2017 Tony has served as a member of the PLC Board in his role as Chief Financial Officer.